Here are 5 deeply discounted stocks to buy – companies that are anywhere from 20% to 50% off of their 52-week highs.
MARKET VALUE: $50.3 billion
52-WEEK RANGE: $110.81-$70.09
% OFF 52-WEEK HIGH: 35.9%
Celgene (CELG) is off more than 30% from its 52-week high, much of which came from October’s downdraft. Generally, investors are nervous about the portion of revenue — north of 60% — that comes from blockbuster drug Revlimid, which treats multiple myeloma, a white blood cell cancer. They’re also nervous that Revlimid will face generic competition starting in 2022.
But investors may be fretting about Revlimid too much and forgetting that Celgene is continuing to grow. Celgene’s profits have expanded by more than 17%, compounded annually, over the past five years. And diluted earnings for the first nine months of 2018 have come to $4.02 per share, already besting last year’s full-year earnings of $3.64.
Celgene actually has a deep pipeline for drugs to treat lymphoma, anemia and multiple sclerosis. Celgene’s formulations are expected to hit the market in 2019 and 2020. Analysts at CFRA — a unit of Standard & Poor’s — believe that Celgene could introduce five meaningful drugs by 2020. Celgene is acquisitive, too, and healthy cash flow from Revlimid can finance new deals while pipeline products gain traction.
MARKET VALUE: $19.5 billion
52-WEEK RANGE: $34.14 – $9.04
% OFF 52-WEEK HIGH: 44.3%
Advanced Micro Devices’ (AMD) stock still is doing fantastically in 2018, up 80% for the year-to-date. Wins in several markets – client CPUs, server GPUs and graphics chips for data centers and gamers – have revived the previously struggling chipmaker.
Still, AMD stock is off by well more than 40% since September amid a broad selloff in technology, and thanks to a disappointing Q3 report. The company’s revenues, while up year-over-year for the fifth straight quarter, missed expectations, as did fourth-quarter guidance.
Stay focused on the longer-term fundamental outlook. Many analysts believe AMD can maintain its momentum and challenge Intel (INTC) and Nvidia (NVDA) through a combination of licensing and customization.
MARKET VALUE: $26.8 billion
52-WEEK RANGE: $151.26-$86.01
% OFF 52-WEEK HIGH: 42.0%
Electronic Arts (EA) makes video games, but it is constantly changing as it strives to provide quality content. EA’s Star Wars: Battlefront is among the top performing games in the industry, and its success is likely to be continued through future editions. Digital sales — versus packaged software — currently contribute more than half of Electronic Arts’ revenue, and management aims to increase that amount in order to benefit from the higher margins on digital, while also enabling it to distribute more of its content to current customers.
The company is putting resources behind its eSports and mobile gaming, which could boost growth. Electronic Arts’ strategy is aided by some compelling macros and trends. Among them are 2.6 billion gamers around the world and EA’s 300 million registered players, who it can market new and upgraded products to.
MARKET VALUE: $5.6 billion
52-WEEK RANGE: $23.08-$15.76
% OFF 52-WEEK HIGH: 22.1%
Low-cost airline JetBlue (JBLU) is also flying well below the clouds, but it has a plan to gain altitude. At a recent investor day, management said the company is aggressively switching capacity from underperforming destinations such as Daytona Beach, St. Croix, Baltimore, Detroit, Pittsburgh, the District of Columbia and Santiago (Dominican Republic), and adding capacity in more profitable routes emanating out of Boston and Fort Lauderdale.
The dip in shares comes at an inflection point in JetBlue’s growth and development. Bank of America/Merrill Lynch thinks that the company has now achieved the scale required to effectively compete in the capital-intensive airline business and can now focus on more returns-oriented investments like its premium Mint service — JetBlue’s version of first class — as well as its cost-cutting initiatives. Airline profits are often a rollercoaster affair, primarily because of fuel costs, but JetBlue expected to keep growing revenues steadily at 9% annually this year and next.
MARKET VALUE: $4.5 billion
52-WEEK RANGE: $127.32-$83.78
% OFF 52-WEEK HIGH: 20.3%
National Beverage (FIZZ, $101.45) has been dogged with shareholder lawsuits and claims that its LaCroix sparkling beverage brand isn’t as natural as the company claims. But these seem like border skirmishes that don’t really detract from the underlying fundamentals of the company, which include a singular focus and growth on both the top and bottom lines.
In September, National Beverage announced it achieved the billion-dollar mark for annual revenues, on Q2 revenues of $292.6 million that marked the company’s 15th consecutive quarter of top-line growth. Earnings, while volatile, increased from $1.01 per share in 2013 to $3.19 in the fiscal year ended April 28, for compound annual growth of nearly 26%. While $1 billion in sales may not sound like much compared to the likes of Coca-Cola (KO), which delivered $35.4 billion in sales last year, National Beverage’s focus on sparkling water and juices creates a much more compelling, albeit riskier, growth profile.
Leave a Tip if You Want
if you found this Website useful, please leave a tip, it will help us to move forward
Looking ahead, initial efforts to penetrate the Canadian market have shown the LaCroix brand to be popular with consumers there, which is encouraging given the strong global demand for sparkling water.